Difficulty: Medium
Average Score: 85%
Practice
Which of the following muscle relaxants can be used to control spasticity associated with upper motor neurone paralysis ?
Correct answer
D
Rationale
The correct answer is D) Baclofen. Baclofen is a centrally acting muscle relaxant that acts as a gamma-aminobutyric acid (GABA) agonist. It is used to treat spasticity associated with upper motor neuron disorders such as multiple sclerosis, spinal cord injuries, and cerebral palsy. Baclofen works by inhibiting the release of excitatory neurotransmitters, thereby reducing muscle spasticity without significantly affecting muscle strength.
Option A) d-tubocurarine is a non-depolarizing neuromuscular blocker that is used as a skeletal muscle relaxant during anesthesia. It is not indicated for spasticity associated with upper motor neuron paralysis.
Option B) Succinylcholine is a depolarizing neuromuscular blocker used for rapid muscle relaxation during intubation or electroconvulsive therapy. It is not suitable for long-term management of spasticity.
Option C) Mephenesin is a skeletal muscle relaxant with sedative properties. It is not commonly used for treating spasticity associated with upper motor neuron paralysis.
Educationally, understanding the mechanism of action and appropriate clinical use of muscle relaxants is crucial for healthcare professionals working with patients with neurological conditions. Knowing the specific indications and contraindications of each muscle relaxant helps in providing safe and effective care for patients with spasticity. Baclofen's unique mechanism of action and its efficacy in managing spasticity make it a preferred choice in treating conditions involving upper motor neuron paralysis.
Option A) d-tubocurarine is a non-depolarizing neuromuscular blocker that is used as a skeletal muscle relaxant during anesthesia. It is not indicated for spasticity associated with upper motor neuron paralysis.
Option B) Succinylcholine is a depolarizing neuromuscular blocker used for rapid muscle relaxation during intubation or electroconvulsive therapy. It is not suitable for long-term management of spasticity.
Option C) Mephenesin is a skeletal muscle relaxant with sedative properties. It is not commonly used for treating spasticity associated with upper motor neuron paralysis.
Educationally, understanding the mechanism of action and appropriate clinical use of muscle relaxants is crucial for healthcare professionals working with patients with neurological conditions. Knowing the specific indications and contraindications of each muscle relaxant helps in providing safe and effective care for patients with spasticity. Baclofen's unique mechanism of action and its efficacy in managing spasticity make it a preferred choice in treating conditions involving upper motor neuron paralysis.